Skip to main content

Table 1 Clinical characteristics of 356 participants by sex

From: Area of the pressure-strain loop during ejection as non-invasive index of left ventricular performance: a population study

Characteristic Men (n = 197) Women (n = 159) P value
Anthropometrics
 Age, y 53.2 ± 14.6 54.8 ± 12.5 0.27
 Body mass index, kg/m2 27.3 ± 3.56 26.5 ± 4.32 0.060
 Systolic BP, mm Hg 131.6 ± 14.8 129.3 ± 17.3 0.18
 Diastolic BP, mm Hg 85.3 ± 9.33 81.4 ± 8.85 < 0.0001
 Pulse pressure, mm Hg 46.3 ± 12.8 48.0 ± 13.8 0.23
 Mean arterial pressure, mm Hg 100.7 ± 9.72 97.4 ± 10.5 0.0020
 Heart rate, bpm 58.5 ± 8.98 60.6 ± 8.71 0.026
Questionnaire data
 Current smoking, n (%) 31 (15.7) 31 (19.5) 0.35
 Drinking alcohol, n (%) 119 (60.4) 37 (23.3) < 0.0001
 Hypertensive, n (%) 100 (50.8) 69 (43.4) 0.17
 Treated for hypertension, n (%) 54 (27.4) 38 (23.9) 0.45
 β-blockers, n (%) 25 (12.7) 18 (11.3) 0.69
 ACE or ARB, n (%) 26 (13.2) 10 (6.3) 0.032
 CCB, n (%) 18 (9.1) 7 (4.4) 0.082
 Diuretics, n (%) 18 (9.1) 16 (10.1) 0.77
 History of diabetes, n (%) 8 (4.1) 8 (5.0) 0.66
Biochemical data
 Serum creatinine, μmol/L 81.6 ± 13.0 66.2 ± 17.9 < 0.0001
 Total cholesterol, mmol/L 4.84 ± 0.93 5.28 ± 0.96 < 0.0001
 Serum insulin, μmol/L 5.20 (2.20–12.0) 4.67 (2.00–10.7) 0.10
  1. Values are mean (±SD), number of subjects (%) or median (10–90% percentile interval). ACE indicates angiotensin-converting enzyme, ARB angiotensin-receptor blockers, bpm beats per minutes, CCB calcium channel blockers